1. Home
  2. VSAT vs SAVA Comparison

VSAT vs SAVA Comparison

Compare VSAT & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • SAVA
  • Stock Information
  • Founded
  • VSAT 1986
  • SAVA 1998
  • Country
  • VSAT United States
  • SAVA United States
  • Employees
  • VSAT N/A
  • SAVA N/A
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSAT Technology
  • SAVA Health Care
  • Exchange
  • VSAT Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • VSAT 1.2B
  • SAVA 1.3B
  • IPO Year
  • VSAT 1996
  • SAVA N/A
  • Fundamental
  • Price
  • VSAT $7.48
  • SAVA $26.91
  • Analyst Decision
  • VSAT Buy
  • SAVA Strong Buy
  • Analyst Count
  • VSAT 7
  • SAVA 3
  • Target Price
  • VSAT $21.14
  • SAVA $111.50
  • AVG Volume (30 Days)
  • VSAT 2.5M
  • SAVA 1.3M
  • Earning Date
  • VSAT 11-06-2024
  • SAVA 11-07-2024
  • Dividend Yield
  • VSAT N/A
  • SAVA N/A
  • EPS Growth
  • VSAT N/A
  • SAVA N/A
  • EPS
  • VSAT N/A
  • SAVA N/A
  • Revenue
  • VSAT $4,527,274,000.00
  • SAVA N/A
  • Revenue This Year
  • VSAT $7.83
  • SAVA N/A
  • Revenue Next Year
  • VSAT $1.84
  • SAVA N/A
  • P/E Ratio
  • VSAT N/A
  • SAVA N/A
  • Revenue Growth
  • VSAT 36.25
  • SAVA N/A
  • 52 Week Low
  • VSAT $7.30
  • SAVA $8.79
  • 52 Week High
  • VSAT $29.11
  • SAVA $42.20
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 23.01
  • SAVA 51.05
  • Support Level
  • VSAT $8.49
  • SAVA $25.00
  • Resistance Level
  • VSAT $11.17
  • SAVA $28.18
  • Average True Range (ATR)
  • VSAT 0.68
  • SAVA 1.81
  • MACD
  • VSAT -0.15
  • SAVA 0.07
  • Stochastic Oscillator
  • VSAT 0.64
  • SAVA 62.39

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Share on Social Networks: